You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ATHE Buy Disclosure
Stamler David Allen · SEC Form 4 · Filed Sep 8, 2026
Buy
Calculated transaction value
$23.81K
Stamler David Allen Chief Executive Officer
ATHE
Transaction date
Aug 31, 2026
Public filing date
Sep 8, 2026
Filing lag
Filed 8 days later
ATHE daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Listed option exp 31 Aug 2026 on Ordinary shares
- Quantity / price
- 47,620 shares @ $0.5
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0002130205-26-000002
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$23.81K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Alterity Therapeutics Ltd ATHE Current | Buy | Aug 31, 2026 | $23.81K |